CAS: 38897-25-5

3-Bromo-4,5-dihydroxybenzonitrile

3-Bromo-4,5-dihydroxybenzonitrile is a molecule that has been found to be effective in treating neurodegenerative diseases. It has been shown to inhibit gene transcription, leading to the inhibition of cell proliferation and apoptosis. This drug also inhibits N-acetylglucosamine glycosylase, an enzyme that is involved in the removal of the amino group from cellular glycerophospholipids. 3-Bromo-4,5-dihydroxybenzonitrile binds to the hydrophobic pocket of DNA and prevents the formation of hydrogen bonds with the nucleobases. 3-Bromo-4,5-dihydroxybenzonitrile is a cochlear toxicant as it can cause hearing loss and deafness when administered at high doses. The cochlear toxicity may be due to its ability to inhibit tyrosine kinase activity, protein phosphatase 2